Product NDC: | 0378-1711 |
Proprietary Name: | Pramipexole Dihydrochloride |
Non Proprietary Name: | pramipexole dihydrochloride |
Active Ingredient(s): | 1 mg/1 & nbsp; pramipexole dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-1711 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077854 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130110 |
Package NDC: | 0378-1711-77 |
Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (0378-1711-77) |
NDC Code | 0378-1711-77 |
Proprietary Name | Pramipexole Dihydrochloride |
Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (0378-1711-77) |
Product NDC | 0378-1711 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pramipexole dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130110 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |